Mary Nyarko

Mary Nyarko

Auto-generated profile, based on publicly available information

Mary Nyarko


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2026 in JMIR Preprints
Verified
Preprint
Open access
SMSusann May
Susann May
MMManuela Marquardt
Manuela Marquardt
GBGina Barzen
Gina Barzen
FSFrances Seifert
Frances Seifert
MNMary Nyarko
Mary Nyarko
FMFelix Muehlensiepen
Felix Muehlensiepen
BACKGROUND Nationwide electronic health records (EHRs) are intended to strengthen patient empowerment and improve information continuity in healthcare. In Germany, the electronic patient record (elektronische Patientenakte, ePA) transitioned from an opt-in to an opt-out model in 2025. Although an ePA is now automatically created for all individuals with statutory health insurance, active use remains voluntary and uptake has been limited. Initial survey data suggest that technical complexity and access requirements may hinder engagement, yet little is known about how insured individuals experience the setup and authentication process. OBJECTIVE This study aimed to explore how insured persons experience the registration and authentication process of the ePA app and to identify barriers that influence successful access. METHODS We conducted a qualitative study based on semi-structured interviews with 23 individuals covered by statutory health insurance in Germany who had experience with or had attempted to initiate the ePA registration process. Data were analyzed using Kuckartz’s structured qualitative content analysis. In addition to phase-specific challenges, cross-phase patterns were inductively condensed into higher-order forms of selectivity shaping access to the ePA. RESULTS Participants described the ePA setup not as a single technical step but as a multi-stage process comprising five sequential phases: orientation, technical entry, verification, interruption, and integration. Barriers accumulated across phases and included fragmented app structures, complex multi-step authentication procedures, technical breakdowns, administrative inconsistencies, and prolonged waiting times. Successful completion of the process depended heavily on individual coping resources such as digital competence, persistence, and self-efficacy. Across the material, five interrelated forms of selectivity were identified: cognitive, capability-based, affective, procedural, and technical-infrastructural selectivity. These mechanisms interacted cumulatively, rendering the authentication pathway selectively passable and prone to dropout, even among digitally competent users. CONCLUSIONS Access to the opt-out ePA is structured by processual and structural selectivity rather than isolated technical problems. Formal universality does not guarantee effective usability. To prevent the reproduction of digital inequalities, implementation strategies must address cumulative burdens across the entire authentication pathway and shift responsibility from individual user capabilities toward coherent system design and supportive infrastructures. CLINICALTRIAL https://www.drks.de/search/de/trial/DRKS00037053 identifier DRKS00037053, Registration Date: 05.06.2025 INTERNATIONAL REGISTERED REPORT RR2-10.1177/20552076251407130

17 September 2026 in JMIR Preprints
Verified
Preprint
Open access
SGSonja Gscheidle
Sonja Gscheidle
SMSusann May
Susann May
GBGina Barzen
Gina Barzen
MNMary Nyarko
Mary Nyarko
ANAntonia Niemeyer
Antonia Niemeyer
SSSebastian Spethmann
Sebastian Spethmann
BACKGROUND In January 2025, Germany changed its electronic patient record (elektronische Patientenakte [ePA]) from an opt-in to an opt-out model, making an ePA available to most individuals with statutory health insurance unless they actively objected. Formal availability, however, does not necessarily result in active use. Little is known about whether facilitators and barriers differ between individuals who actively use the ePA, those who have an ePA but do not use it (nonactive users), and those who deliberately opt out (non-users). OBJECTIVE This study explored and compared facilitators and barriers to ePA use across these three user groups and examined how the identified factors relate to an established technology acceptance framework. METHODS We conducted a qualitative interview study within the “ePA4all” project. Active users, nonactive users, and non-users were recruited for semistructured interviews via purposive and snowball sampling using multiple channels. Data were analyzed using structured qualitative content analysis according to Kuckartz, combining deductive and inductive approaches: facilitators and barriers served as deductive main categories, while subcategories were developed inductively. Resulting categories were interpreted using the Unified Theory of Acceptance and Use of Technology (UTAUT), extended by the dimensions of trust and data privacy. RESULTS Between May and December 2025, we conducted 61 interviews with 21 active users, 20 nonactive users, and 20 non-users in Germany. Active users perceived substantial potential value but continued to experience access barriers and limited integration of the ePA into routine care. Nonactive users recognized potential benefits but reported limited personal relevance, insufficient knowledge, and anticipated access complexity. Non-users raised concerns about data privacy, security, governance, and institutional trust. Across user groups, simplified access to the ePA application, targeted information, and clearer integration into routine care emerged as key prerequisites for wider adoption. CONCLUSIONS The transition to an opt-out model addresses the availability of the ePA but does not by itself ensure activation, meaningful use, or acceptance of its governance model. Different forms of non-use reflected different underlying barriers: limited activation and information among individuals with an unused ePA, and trust-, governance-, and autonomy-related concerns among many opt-out participants. Implementation strategies should therefore distinguish between enabling access and use and supporting informed decisions about participation. CLINICALTRIAL German Clinical Trials Register DRKS00037053; https://www.drks.de/search/de/trial/DRKS00037053; registration date: June 5, 2025 (retrospectively registered)

14 September 2026 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SMSusann May
Susann May
MMManuela Marquardt
Manuela Marquardt
GBGina Barzen
Gina Barzen
FSFrances Seifert
Frances Seifert
MNMary Nyarko
Mary Nyarko
FMFelix Muehlensiepen
Felix Muehlensiepen
Background: Nationwide electronic health records (EHRs) are intended to strengthen patient empowerment and improve information continuity across health care settings. In Germany, the electronic patient record (elektronische Patientenakte [ePA]) transitioned from an opt-in to an opt-out model in 2025. Initial survey data suggest that technical complexity and access requirements may hinder engagement; yet, little is known about how users experience this access process. Objective: This study explored users’ experiences of setting up and authenticating access to insurer-provided ePA apps and examined the barriers affecting successful access. Methods: We conducted a qualitative interview study with individuals covered by statutory health insurance. From 61 interviews conducted within the broader ePA4all project, 23 were selected because participants had attempted to access the ePA through an insurer-provided application and described at least 1 concrete action or event during setup or authentication. Semistructured telephone interviews were conducted between August and December 2025. Data were analyzed using Kuckartz’s structured qualitative content analysis. The process phases were developed inductively from the material. All 23 interviews were independently coded by 2 researchers, with differences resolved through consensus. A second analytic step examined how barriers interacted and accumulated across the access pathway. Results: The sample included 21 participants who had successfully accessed the ePA and 2 who had initiated but abandoned setup or authentication. Setup and authentication were experienced not as a single technical step but as an interdependent process comprising 5 phases: orientation, technical entry, verification, interruption, and transition to initial use. During orientation, incomplete or outdated information left requirements and procedural steps unclear. Technical entry required users to coordinate different apps, interfaces, and device requirements. Verification involved multiple credentials, identification services, and partly repeated security steps. Technical failures, administrative inconsistencies, postal procedures, and waiting periods interrupted progression and sometimes required users to repeat previously completed steps. After successful access, an unclear immediate benefit could limit the transition to initial use. Across phases, participants relied on digital competence, prior experience, persistence, and self-efficacy to navigate the process. Difficulties were also reported by participants with high affinity for technology. Barriers could accumulate across phases: insufficient orientation increased subsequent coordination work, failures produced interruptions and repeated attempts, and prolonged effort contributed to frustration or disengagement. Conclusions: Access to the opt-out ePA through insurer-provided apps is shaped by cumulative demands rather than by isolated technical problems. Formal provision of an EHR does not ensure that users can successfully complete the access process. Implementation should prioritize clear preregistration guidance, continuity across applications and identification services, resumable procedures, actionable error messages, and accessible support. More broadly, onboarding and authentication should be treated as integral stages in the implementation of patient-facing digital health infrastructures rather than as neutral technical prerequisites. Trial Registration: German Clinical Trials Register DRKS00037053; https://www.drks.de/search/de/trial/DRKS00037053 International Registered Report Identifier (IRRID): RR2-10.1177/20552076251407130